Nikolaus Schultz
0000-0002-0131-4904
Publication & Citation Trends
Publications
0 total
Abstract 4097: cBioPortal for cancer genomics
Cited by 0
Semantic Scholar
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer OA
Cited by 13
Semantic Scholar
Pan-cancer analysis of biallelic inactivation patterns in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer OA
Cited by 16
Semantic Scholar
Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer. OA
Cited by 0
Semantic Scholar
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses OA
Cited by 5
Semantic Scholar
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers OA
Cited by 49
Semantic Scholar
Author Correction: Pan-cancer analysis of whole genomes OA
Cited by 11
Semantic Scholar
Quantifying the growth of clinical actionability in precision oncology using OncoKB.
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(589)
Lung Cancer Treatments and Mutations
(294)
Gastric Cancer Management and Outcomes
(261)
Esophageal Cancer Research and Treatment
(219)
Prostate Cancer Treatment and Research
(153)
Affiliations
Broad Institute
Boston University
James S. McDonnell Foundation
University of Southern California
Roche (Switzerland)
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.